Full name
AMBER PHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
38.12.Z - Collection of hazardous waste
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.78.Z - Retail sale of other new products
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
58.19.Z - Other publishing activities, excluding software publishing
73.11.Z - Advertising agency activities
73.12.D - Advertising through mass media
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,5 | 1,7 | 2,5 | 45,1 |
EBITDA | 0,8 | 2 | 2,8 | 42,3 |
Short time liabilities | 7,1 | 7,9 | 9,1 | 15 |
Equity capital | 2 | 3,3 | 5,3 | 59,5 |
Operating profit (EBIT) | 0,5 | 1,8 | 2,6 | 46,9 |
Assets | 9,4 | 12,5 | 15,5 | 23,6 |
Net profit (loss) | 0,5 | 1,3 | 2 | 52,6 |
Cash | 0,4 | 0,6 | 0,7 | 3,1 |
Net income from sale | 53,3 | 58,1 | 68,4 | 17,7 |
Liabilities and provisions for liabilities | 7,4 | 9,2 | 10,2 | 10,6 |
Working assets | 7,5 | 9 | 12,1 | 34,7 |
Depreciation | 0,3 | 0,2 | 0,2 | 3,5 |
% | % | % | p.p. | |
Profitability of capital | 24,3 | 39 | 37,3 | -1,7 |
Equity capital to total assets | 21,6 | 26,7 | 34,4 | 7,7 |
Gross profit margin | 1 | 2,9 | 3,6 | 0,7 |
EBITDA Margin | 1,5 | 3,4 | 4,1 | 0,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 49 | 50 | 49 | -1 |
Current financial liquidity indicator | ||||
Net dept to EBITDA |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane